Endocrinol Metab.  2024 Dec;39(6):891-898. 10.3803/EnM.2024.1996.

Rising Incidence and Comorbidities of Endogenous Hypothyroidism in Republic of Korea from 2004 to 2018: A Nationwide Population Study

Affiliations
  • 1Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea
  • 2Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea
  • 3Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
  • 4Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea

Abstract

Background
Hypothyroidism, a prevalent endocrine disorder, results from insufficient thyroid hormone production or release, affecting metabolism. However, disparities in comorbidities and treatment trajectories may exist between endogenous and exogenous hypothyroidism.
Methods
Data from the Korean National Health Insurance Service from 2004 to 2018. Endogenous hypothyroidism was defined as cases with two or more diagnostic codes for hypothyroidism coupled with a history of thyroid hormone intake exceeding 60 days. To eliminate iatrogenic hypothyroidism, individuals with diagnosis codes for thyroid cancer, treatment codes for thyroid surgery, or radiotherapy were excluded. Hypothyroidism-related comorbidities were defined as new occurrences of the corresponding diagnosis code after the diagnosis of hypothyroidism during the entire study period.
Results
The age-standardized incidence of endogenous hypothyroidism among men was 0.2 per 1,000 person-years in 2004, increasing to 0.8 in 2018. Among women, the incidence increased from 1.6 per 1,000 person-years in 2004 to 3.7 in 2018. When comparing age groups of 20s–50s and 60s–90s, both sexes in the 60s–90s demonstrated a more rapid increase in incidence than those in the 20s–50s age range. Patients with endogenous hypothyroidism demonstrated a higher incidence of mood disorders across all age groups and cerebrovascular disease in individuals ≥60 years old, regardless of sex.
Conclusion
In Republic of Korea, endogenous hypothyroidism incidence has been increased in recent years. The incidence of endogenous hypothyroidism is increasing more rapidly in men than in women, especially in the elderly. Patients with endogenous hypothyroidism seem to have a heightened risk for cerebrovascular disease and mood disorders.

Keyword

Endogenous hypothyroidism; Republic of Korea; Prevalence; Incidence; Comorbidity

Figure

  • Fig. 1. Nationwide age-standardized incidence rate of endogenous hypothyroidism in South Korea (2004 to 2018) kept increasing in men and women.

  • Fig. 2. Incidence of endogenous hypothyroidism was compared between 2004–2005 and 2017–2018 and between (A) men and (B) women. aP<0.05.

  • Fig. 3. Incidence of endogenous hypothyroidism was compared between 20s–50s and 60s–90s and between (A) men and (B) women.

  • Fig. 4. Occurrence of comorbidities following endogenous hypothyroidism diagnosis was compared between hypothyroidism and the general population in men and women. Comorbidities include (A) ischemic heart disease, (B) cerebrovascular disease, (C) mood disorder, (D) cognitive disorder, and (E) dementia.


Reference

1. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017; 390:1550–62.
Article
2. Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers. 2022; 8:30.
Article
3. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002; 87:489–99.
4. Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid. 2007; 17:1211–23.
Article
5. Asvold BO, Vatten LJ, Bjoro T. Changes in the prevalence of hypothyroidism: the HUNT Study in Norway. Eur J Endocrinol. 2013; 169:613–20.
Article
6. Kwon H, Jung JH, Han KD, Park YG, Cho JH, Lee DY, et al. Prevalence and annual incidence of thyroid disease in Korea from 2006 to 2015: a nationwide population-based cohort study. Endocrinol Metab (Seoul). 2018; 33:260–7.
Article
7. Kim EH, Jeon YK, Pak K, Kim IJ, Kim SJ, Shin S, et al. Effects of thyrotropin suppression on bone health in menopausal women with total thyroidectomy. J Bone Metab. 2019; 26:31–8.
8. Xia Q, Dong S, Bian PD, Wang J, Li CJ. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma. Eur Arch Otorhinolaryngol. 2016; 273:1037–43.
Article
9. Seo GH, Chung JH. Incidence and prevalence of overt hypothyroidism and causative diseases in Korea as determined using claims data provided by the Health Insurance Review and Assessment Service. Endocrinol Metab (Seoul). 2015; 30:288–96.
Article
10. Seong SC, Kim YY, Khang YH, Park JH, Kang HJ, Lee H, et al. Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017; 46:799–800.
11. Garmendia Madariaga A, Santos Palacios S, Guillen-Grima F, Galofre JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014; 99:923–31.
12. National Health Insurance Service. Number of visits to medical institutions per person [Internet]. Daejeon: Statistics Korea;2023. [cited 2024 Aug 1]. Available from: https://www.index.go.kr/unify/idx-info.do?idxCd=4240&clasCd=7.
13. Korean Statistical Information Service. Population Dynamics and Birth Rate Trends [Internet]. Daejeon: KOSIS;2024. [cited 2024 Aug 1]. Available from: https://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1B8000F&conn_path=I2&language=en_.
14. Concepcion-Zavaleta MJ, Coronado-Arroyo JC, Quiroz-Aldave JE, Concepcion-Urteaga LA, Paz-Ibarra J. Thyroid dysfunction and female infertility: a comprehensive review. Diabetes Metab Syndr. 2023; 17:102876.
15. Zhang S, Yang M, Li T, Yang M, Wang W, Chen Y, et al. High level of thyroid peroxidase antibodies as a detrimental risk of pregnancy outcomes in euthyroid women undergoing ART: a meta-analysis. Mol Reprod Dev. 2023; 90:218–26.
16. Lee J, Yeoh Y, Seo MJ, Lee GH, Kim CI. Estimation of dietary iodine intake of Koreans through a Total Diet Study (TDS). Korean J Community Nutr. 2021; 26:48–55.
17. Ko YM, Kwon YS, Park YK. An iodine database establishment and iodine intake in Korean adults: based on the 1998-2014 Korea National Health and Nutrition Examination Survey. J Nutr Health. 2017; 50:624–44.
Article
18. Jung KY, Kim H, Choi HS, An JH, Cho SW, Kim HJ, et al. Clinical factors predicting the successful discontinuation of hormone replacement therapy in patients diagnosed with primary hypothyroidism. PLoS One. 2020; 15:e0233596.
Article
19. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med. 2005; 165:2460–6.
20. Hyland KA, Arnold AM, Lee JS, Cappola AR. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. J Clin Endocrinol Metab. 2013; 98:533–40.
21. Moon S, Kim MJ, Yu JM, Yoo HJ, Park YJ. Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Thyroid. 2018; 28:1101–10.
Article
22. Yang MH, Yang FY, Lee DD. Thyroid disease as a risk factor for cerebrovascular disease. J Stroke Cerebrovasc Dis. 2015; 24:912–20.
23. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, et al. Recommendations for the diagnosis and management of Alzheimer’s disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol. 2007; 14:e1–26.
24. Ye Y, Wang Y, Li S, Guo J, Ding L, Liu M. Association of hypothyroidism and the risk of cognitive dysfunction: a meta-analysis. J Clin Med. 2022; 11:6726.
25. Akintola AA, Jansen SW, van Bodegom D, van der Grond J, Westendorp RG, de Craen AJ, et al. Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis. Front Aging Neurosci. 2015; 7:150.
26. Wu Y, Pei Y, Wang F, Xu D, Cui W. Higher FT4 or TSH below the normal range are associated with increased risk of dementia: a meta-analysis of 11 studies. Sci Rep. 2016; 6:31975.
Full Text Links
  • ENM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr